株式会社ツーセル
2 known investors
Two Cells develops regenerative medicine treatments using mesenchymal stem cells (MSCs) that are extracted, expanded outside the body, and transplanted into patients. The company focuses on MSC-based regenerative medicine therapies.
BiotechHealthtechMedical Devices